EFS ADA Vector

ADA gene therapy vector · University of California, Los Angeles

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EFS ADA Vector, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency Using Peripheral Blood and EFS ADA Vector [Phase 1, Phase 2]

See pricing